ABCL logo

AbCellera Biologics Inc. (ABCL) Total liabilities

annual total liabilities:

$154.58M-$85.28M(-35.56%)
December 31, 2024

Summary

  • As of today (August 29, 2025), ABCL annual total liabilities is $154.58 million, with the most recent change of -$85.28 million (-35.56%) on December 31, 2024.
  • During the last 3 years, ABCL annual total liabilities has fallen by -$138.26 million (-47.21%).
  • ABCL annual total liabilities is now -49.75% below its all-time high of $307.63 million, reached on December 31, 2022.

Performance

ABCL Total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLbalance sheet metrics

quarterly total liabilities:

$227.45M+$63.42M(+38.66%)
June 1, 2025

Summary

  • As of today (August 29, 2025), ABCL quarterly total liabilities is $227.45 million, with the most recent change of +$63.42 million (+38.66%) on June 1, 2025.
  • Over the past year, ABCL quarterly total liabilities has increased by +$50.13 million (+28.27%).
  • ABCL quarterly total liabilities is now -40.89% below its all-time high of $384.78 million, reached on March 31, 2022.

Performance

ABCL quarterly total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLbalance sheet metrics

Total liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

ABCL Total liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-35.6%+28.3%
3 y3 years-47.2%-40.3%
5 y5 years+1067.8%+253.6%

ABCL Total liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-49.8%at low-40.3%+47.1%
5 y5-year-49.8%+1067.8%-40.9%+328.0%
alltimeall time-49.8%+1464.1%-40.9%+1618.4%

ABCL Total liabilities History

DateAnnualQuarterly
Jun 2025
-
$227.45M(+38.7%)
Mar 2025
-
$164.03M(+6.1%)
Dec 2024
$154.58M(-35.6%)
$154.58M(-10.5%)
Sep 2024
-
$172.69M(-2.6%)
Jun 2024
-
$177.33M(-20.3%)
Mar 2024
-
$222.60M(-7.2%)
Dec 2023
$239.86M(-22.0%)
$239.86M(-27.2%)
Sep 2023
-
$329.42M(-3.8%)
Jun 2023
-
$342.34M(+18.3%)
Mar 2023
-
$289.42M(-5.9%)
Dec 2022
$307.63M
$307.63M(+1.8%)
DateAnnualQuarterly
Sep 2022
-
$302.24M(-20.7%)
Jun 2022
-
$380.93M(-1.0%)
Mar 2022
-
$384.78M(+31.4%)
Dec 2021
$292.84M(+67.3%)
$292.84M(+33.5%)
Sep 2021
-
$219.34M(+19.1%)
Jun 2021
-
$184.18M(+7.5%)
Mar 2021
-
$171.40M(-2.1%)
Dec 2020
$175.03M(+1222.4%)
$175.03M(+229.3%)
Sep 2020
-
$53.15M(-17.4%)
Jun 2020
-
$64.32M(+386.0%)
Dec 2019
$13.24M(+33.9%)
$13.24M
Dec 2018
$9.88M
-

FAQ

  • What is AbCellera Biologics Inc. annual total liabilities?
  • What is the all time high annual total liabilities for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. annual total liabilities year-on-year change?
  • What is AbCellera Biologics Inc. quarterly total liabilities?
  • What is the all time high quarterly total liabilities for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. quarterly total liabilities year-on-year change?

What is AbCellera Biologics Inc. annual total liabilities?

The current annual total liabilities of ABCL is $154.58M

What is the all time high annual total liabilities for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high annual total liabilities is $307.63M

What is AbCellera Biologics Inc. annual total liabilities year-on-year change?

Over the past year, ABCL annual total liabilities has changed by -$85.28M (-35.56%)

What is AbCellera Biologics Inc. quarterly total liabilities?

The current quarterly total liabilities of ABCL is $227.45M

What is the all time high quarterly total liabilities for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high quarterly total liabilities is $384.78M

What is AbCellera Biologics Inc. quarterly total liabilities year-on-year change?

Over the past year, ABCL quarterly total liabilities has changed by +$50.13M (+28.27%)
On this page